These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 2266390)
1. SPECT quantitation of iodine-131 concentration in phantoms and human tumors. Israel O; Iosilevsky G; Front D; Bettman L; Frenkel A; Ish-Shalom S; Steiner M; Ben-Harush M; Kolodny GM J Nucl Med; 1990 Dec; 31(12):1945-9. PubMed ID: 2266390 [TBL] [Abstract][Full Text] [Related]
2. Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG). Fitzgerald PA; Goldsby RE; Huberty JP; Price DC; Hawkins RA; Veatch JJ; Dela Cruz F; Jahan TM; Linker CA; Damon L; Matthay KK Ann N Y Acad Sci; 2006 Aug; 1073():465-90. PubMed ID: 17102115 [TBL] [Abstract][Full Text] [Related]
3. [131I]metaiodobenzylguanidine therapy in carcinoid tumors. Castellani MR; Di Bartolomeo M; Maffioli L; Zilembo N; Gasparini M; Buraggi GL J Nucl Biol Med (1991); 1991; 35(4):349-51. PubMed ID: 1823855 [TBL] [Abstract][Full Text] [Related]
4. [Diagnosis and therapy of neuroectodermal tumors]. Adolph J; Kimmig B Radiologe; 1989 Jan; 29(1):32-42. PubMed ID: 2537501 [TBL] [Abstract][Full Text] [Related]
11. High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma. Rose B; Matthay KK; Price D; Huberty J; Klencke B; Norton JA; Fitzgerald PA Cancer; 2003 Jul; 98(2):239-48. PubMed ID: 12872341 [TBL] [Abstract][Full Text] [Related]
12. Factors affecting 131I-Lym-1 pharmacokinetics and radiation dosimetry in patients with non-Hodgkin's lymphoma and chronic lymphocytic leukemia. DeNardo GL; DeNardo SJ; Shen S; DeNardo DA; Mirick GR; Macey DJ; Lamborn KR J Nucl Med; 1999 Aug; 40(8):1317-26. PubMed ID: 10450684 [TBL] [Abstract][Full Text] [Related]
13. Treatment of malignant pheochromocytoma with a new radiopharmaceutical. Sisson J; Shapiro B; Beierwaltes WH; Nakajo M; Glowniak J; Mangner T; Carey JE; Swanson DP; Copp J; Satterlee W Trans Assoc Am Physicians; 1983; 96():209-17. PubMed ID: 6679954 [TBL] [Abstract][Full Text] [Related]
14. Localization procedures in pheochromocytoma and neuroblastoma. Fischer M; Galanski M; Winterberg B; Vetter H Cardiology; 1985; 72 Suppl 1():143-6. PubMed ID: 3902227 [TBL] [Abstract][Full Text] [Related]
15. [Radioisotope therapy of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine--absorbed dose assessments using SPECT]. Aritake S Kaku Igaku; 1992 Jun; 29(6):667-78. PubMed ID: 1640651 [TBL] [Abstract][Full Text] [Related]
16. Patient dosimetry after 131I-MIBG therapy for neuroblastoma and carcinoid tumours. Monsieurs MA; Thierens HM; Vral A; Brans B; De Ridder L; Dierckx RA Nucl Med Commun; 2001 Apr; 22(4):367-74. PubMed ID: 11338046 [TBL] [Abstract][Full Text] [Related]
17. Quantitative study of radioiodinated metaiodobenzylguanidine uptake in children with neuroblastoma: correlation with tumor histopathology. Moyes JS; Babich JW; Carter R; Meller ST; Agrawal M; McElwain TJ J Nucl Med; 1989 Apr; 30(4):474-80. PubMed ID: 2738676 [TBL] [Abstract][Full Text] [Related]
18. Renal excretion of meta-iodobenzylguanidine after therapeutic doses in cancer patients and its relation to dose and creatinine clearance. Wafelman AR; Nortier YL; Rosing H; Maessen HJ; Taal BG; Hoefnagel CA; Maes RA; Beijnen JH Nucl Med Commun; 1995 Sep; 16(9):767-72. PubMed ID: 7478409 [TBL] [Abstract][Full Text] [Related]
19. [Radionuclide therapy of Sipple syndrome using iodine-131 metaiodobenzylguanidine]. Furusawa M; Shimomura O; Tomiguchi S; Hirota Y; Takahashi M; Yamauchi J; Iwaoka D; Satoh T Kaku Igaku; 1992 Sep; 29(9):1133-8. PubMed ID: 1360550 [TBL] [Abstract][Full Text] [Related]